Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India
The company is the second big medtech to announce a major investment in R&D in the country in 2020.
You may also be interested in...
Five-year investment will expand R&D center in Hyderabad and add 1,000 to workforce.
Siemens Healthineers ̶ an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.